세계의 자폐스펙트럼장애 치료제 시장(2025-2029년)

The autism spectrum disorder therapeutics market is forecasted to grow by USD 825.9 mn during 2024-2029, accelerating at a CAGR of 6.9% during the forecast period. The report on the autism spectrum disorder therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of asd, growing number of public-private partnerships, and growing awareness about autism spectrum disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's autism spectrum disorder therapeutics market is segmented as below:

By Distribution Channel

• Retail pharmacy
• Hospital pharmacy
• Online pharmacy

By Type

• Stimulants
• Selective serotonin reuptake inhibitors
• Antipsychotic drugs
• Sleep medications
• Others

By Application

• Autistic disorder
• Asperger syndrome
• Pervasive developmental disorder
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing interest in personalized medicine for treatment of asd as one of the prime reasons driving the autism spectrum disorder therapeutics market growth during the next few years. Also, growing use of digital therapeutics and rise in exploration of enzyme replacement therapy (ERT) for asd will lead to sizable demand in the market.

The report on the autism spectrum disorder therapeutics market covers the following areas:

• Autism Spectrum Disorder Therapeutics Market sizing
• Autism Spectrum Disorder Therapeutics Market forecast
• Autism Spectrum Disorder Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autism spectrum disorder therapeutics market vendors that include AutismSTEP, Bristol Myers Squibb Co., CureMark LLC, F. Hoffmann La Roche Ltd., Fraser, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Les Laboratoires Servier, Neurim Pharmaceuticals Ltd., Novartis AG, Oryzon Genomics SA, Otsuka Holdings Co. Ltd., Q BioMed Inc., Scioto Biosciences Inc., Stalicla SA, Travere Therapeutics Inc., and Yamo Pharmaceuticals LLC. Also, the autism spectrum disorder therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Autism Spectrum Disorder Therapeutics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Autism Spectrum Disorder Therapeutics Market 2019 - 2023 ($ million)
• 5.2 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.3 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ million)
• 5.4 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The impact of AI in the global autism spectrum disorder therapeutics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

• 8.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 8.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 8.3 Retail pharmacy - Market size and forecast 2024-2029
  • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
• 8.4 Hospital pharmacy - Market size and forecast 2024-2029
  • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
• 8.5 Online pharmacy - Market size and forecast 2024-2029
  • Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
  • Chart on Type - Market share 2024-2029 (%)
  • Data Table on Type - Market share 2024-2029 (%)
• 9.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 9.3 Stimulants - Market size and forecast 2024-2029
  • Chart on Stimulants - Market size and forecast 2024-2029 ($ million)
  • Data Table on Stimulants - Market size and forecast 2024-2029 ($ million)
  • Chart on Stimulants - Year-over-year growth 2024-2029 (%)
  • Data Table on Stimulants - Year-over-year growth 2024-2029 (%)
• 9.4 Selective serotonin reuptake inhibitors - Market size and forecast 2024-2029
  • Chart on Selective serotonin reuptake inhibitors - Market size and forecast 2024-2029 ($ million)
  • Data Table on Selective serotonin reuptake inhibitors - Market size and forecast 2024-2029 ($ million)
  • Chart on Selective serotonin reuptake inhibitors - Year-over-year growth 2024-2029 (%)
  • Data Table on Selective serotonin reuptake inhibitors - Year-over-year growth 2024-2029 (%)
• 9.5 Antipsychotic drugs - Market size and forecast 2024-2029
  • Chart on Antipsychotic drugs - Market size and forecast 2024-2029 ($ million)
  • Data Table on Antipsychotic drugs - Market size and forecast 2024-2029 ($ million)
  • Chart on Antipsychotic drugs - Year-over-year growth 2024-2029 (%)
  • Data Table on Antipsychotic drugs - Year-over-year growth 2024-2029 (%)
• 9.6 Sleep medications - Market size and forecast 2024-2029
  • Chart on Sleep medications - Market size and forecast 2024-2029 ($ million)
  • Data Table on Sleep medications - Market size and forecast 2024-2029 ($ million)
  • Chart on Sleep medications - Year-over-year growth 2024-2029 (%)
  • Data Table on Sleep medications - Year-over-year growth 2024-2029 (%)
• 9.7 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 9.8 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 10.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 10.3 Autistic disorder - Market size and forecast 2024-2029
  • Chart on Autistic disorder - Market size and forecast 2024-2029 ($ million)
  • Data Table on Autistic disorder - Market size and forecast 2024-2029 ($ million)
  • Chart on Autistic disorder - Year-over-year growth 2024-2029 (%)
  • Data Table on Autistic disorder - Year-over-year growth 2024-2029 (%)
• 10.4 Asperger syndrome - Market size and forecast 2024-2029
  • Chart on Asperger syndrome - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asperger syndrome - Market size and forecast 2024-2029 ($ million)
  • Chart on Asperger syndrome - Year-over-year growth 2024-2029 (%)
  • Data Table on Asperger syndrome - Year-over-year growth 2024-2029 (%)
• 10.5 Pervasive developmental disorder - Market size and forecast 2024-2029
  • Chart on Pervasive developmental disorder - Market size and forecast 2024-2029 ($ million)
  • Data Table on Pervasive developmental disorder - Market size and forecast 2024-2029 ($ million)
  • Chart on Pervasive developmental disorder - Year-over-year growth 2024-2029 (%)
  • Data Table on Pervasive developmental disorder - Year-over-year growth 2024-2029 (%)
• 10.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.12 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.13 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.15 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.16 Spain - Market size and forecast 2024-2029
  • Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Data Table on Spain - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AutismSTEP
  • AutismSTEP - Overview
  • AutismSTEP - Product / Service
  • AutismSTEP - Key offerings
  • SWOT
• 15.5 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
  • SWOT
• 15.6 CureMark LLC
  • CureMark LLC - Overview
  • CureMark LLC - Product / Service
  • CureMark LLC - Key offerings
  • SWOT
• 15.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.8 Fraser
  • Fraser - Overview
  • Fraser - Product / Service
  • Fraser - Key offerings
  • SWOT
• 15.9 Jazz Pharmaceuticals Plc
  • Jazz Pharmaceuticals Plc - Overview
  • Jazz Pharmaceuticals Plc - Product / Service
  • Jazz Pharmaceuticals Plc - Key news
  • Jazz Pharmaceuticals Plc - Key offerings
  • SWOT
• 15.10 Les Laboratoires Servier
  • Les Laboratoires Servier - Overview
  • Les Laboratoires Servier - Business segments
  • Les Laboratoires Servier - Key offerings
  • Les Laboratoires Servier - Segment focus
  • SWOT
• 15.11 Neurim Pharmaceuticals Ltd.
  • Neurim Pharmaceuticals Ltd. - Overview
  • Neurim Pharmaceuticals Ltd. - Product / Service
  • Neurim Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 15.12 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.13 Oryzon Genomics SA
  • Oryzon Genomics SA - Overview
  • Oryzon Genomics SA - Product / Service
  • Oryzon Genomics SA - Key offerings
  • SWOT
• 15.14 Otsuka Holdings Co. Ltd.
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key news
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Segment focus
  • SWOT
• 15.15 Q BioMed Inc.
  • Q BioMed Inc. - Overview
  • Q BioMed Inc. - Product / Service
  • Q BioMed Inc. - Key offerings
  • SWOT
• 15.16 Scioto Biosciences Inc.
  • Scioto Biosciences Inc. - Overview
  • Scioto Biosciences Inc. - Product / Service
  • Scioto Biosciences Inc. - Key offerings
  • SWOT
• 15.17 Stalicla SA
  • Stalicla SA - Overview
  • Stalicla SA - Product / Service
  • Stalicla SA - Key offerings
  • SWOT
• 15.18 Yamo Pharmaceuticals LLC
  • Yamo Pharmaceuticals LLC - Overview
  • Yamo Pharmaceuticals LLC - Product / Service
  • Yamo Pharmaceuticals LLC - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations